Dexivacaine
- Level
- Commodity
- Parent
- 51273000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51273003This classification denotes an anesthetic agent with the molecular formula C15H22N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QI846AL4NC, chemically known as 2-piperidinecarboxamide, n-(2,6-dimethylphenyl)-1-methyl-, (s)- but generally known as dexivacaine, which bears US NIH Compound Identifier 3032799. European Medicines Agency schedules Dexivacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07033MIG. The term DEXIVACAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). DEXIVACAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dexivacaine under HS 29333999 and SITC 51574. As of Q4 2014, DEXIVACAINE remains the US FDA Preferred Term for this commodity. Dexivacaine bears US NLM identifiers UMLS ID C0604558 and NCI Concept Code C65371. SMILES: O=C(NC1C(CCCC1C)C)C1N(CCCC1)C.
Same parent
Under 51273000 · 24Activities that produce or sell this
KBLI · 8Inherited from family 51270000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.